染NK细胞为固体瘤治疗的抗原特异性
Carina A Doeppner1,2,3,4,5, Amanda Katharina Binder1,2,3,4,5, Franziska Bremm1,2,3,4,5
1Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
International journal of molecular sciences
|July 12, 2025
概括
化学抗原受体自然杀手 (CAR-NK) 细胞疗法在治疗固体瘤方面表现有前途,与CAR-T细胞疗法相比,具有更少的副作用和更广泛的适用性,具有潜在的优势.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 癌症是全球主要的死亡原因,目前的免疫疗法,如检查点抑制剂和CAR-T细胞疗法显示出局限性,特别是在固体瘤.
- 自然杀手 (NK) 细胞具有天生的向癌症的能力.
- 化学抗原受体 (CARs) 是工程受体,增强免疫细胞的识别和杀死癌细胞.
研究的目的:
- 审查癌症治疗中CAR-NK细胞疗法的最新进展.
- 与现有治疗方法相比,探索CAR-NK细胞疗法的潜在优势和挑战.
- 讨论改善CAR-NK细胞疗效和潜在组合疗法的策略.
主要方法:
- 关于CAR-NK细胞疗法的当前科学文献的综述.
- 早期实验室和临床研究结果的分析.
- 对NK细胞的CAR工程技术的探索.
主要成果:
- CAR-NK细胞疗法显示出治疗固体瘤的潜力,早期研究显示出有希望的结果.
- 与CAR-T细胞相比,CAR-NK细胞可能提供更好的安全性,包括减少严重的免疫反应和非标效应.
- 全基性CAR-NK细胞应用是可行的,允许现成产品和更大的可访问性.
结论:
- CAR-NK细胞疗法代表了癌症免疫疗法的一个有前途的进步,特别是在固体瘤.
- 需要进一步的研究来克服诸如高效的CAR-NK细胞生产和克服瘤微环境等挑战.
- CAR-NK细胞疗法有可能与其他癌症治疗相结合,以改善患者的治疗结果.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cytotoxic T Cells-mediated Immune Response
2.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.3K
Cells of the Innate Immune Response
3.5K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


